The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
A Model to Predict Survival in Patients With End–Stage Liver Disease
Abstract
A recent mandate emphasizes severity of liver disease to determine priorities in allocating organs for liver transplantation and necessitates a disease severity index based on generalizable, verifiable, and easily obtained variables. The aim of the study was to examine the generalizability of a model previously created to estimate survival of patients undergoing the transjugular intrahepatic portosystemic shunt (TIPS) procedure in patient groups with a broader range of disease severity and etiology. The Model for End–Stage Liver Disease (MELD) consists of serum bilirubin and creatinine levels, International Normalized Ratio (INR) for prothrombin time, and etiology of liver disease. The model's validity was tested in 4 independent data sets, including (1) patients hospitalized for hepatic decompensation (referred to as “hospitalized” patients), (2) ambulatory patients with noncholestatic cirrhosis, (3) patients with primary biliary cirrhosis (PBC), and (4) unselected patients from the 1980s with cirrhosis (referred to as “historical” patients). In these patients, the model's ability to classify patients according to their risk of death was examined using the concordance (c)–statistic. The MELD scale performed well in predicting death within 3 months with a c–statistic of (1) 0.87 for hospitalized patients, (2) 0.80 for noncholestatic ambulatory patients, (3) 0.87 for PBC patients, and (4) 0.78 for historical cirrhotic patients. Individual complications of portal hypertension had minimal impact on the model's prediction (range of improvement in c–statistic: <.01 for spontaneous bacterial peritonitis and variceal hemorrhage to ascites: 0.01–0.03). The MELD scale is a reliable measure of mortality risk in patients with end–stage liver disease and suitable for use as a disease severity index to determine organ allocation priorities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941
Malinchoc, M., Kamath, P. S., Gordon, F. D., Peine, C. J., Rank, J., & ter Borg, P. C. J. (2000) · Hepatology · doi:10.1053/he.2000.5852 · Cited by 2,893
Self-citationPrognosis in primary biliary cirrhosis: Model for decision making
Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816 · cited 1×
“MELD 9 (4-14) 10 (8-13) 1 (22-5) 7 (3-13)”
Ursodiol for Primary Sclerosing Cholangitis
Lindor, K. D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361003 · Cited by 598
Grambsch, P. M., Dickson, R. E., Kaplan, M., Lesage, G., Fleming, T. R., & Langworthy, A. L. (1989) · Hepatology · doi:10.1002/hep.1840100516 · Cited by 107
Self-citation
Cited by
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“UNOS developed a priority system to manage waiting lists for transplantation based on the MELD score [218], which was originally generated to predict 3-month survival in patients with End-Stage Liver Disease [221].”
MethodVillanueva, A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1713263 · Cited by 4,508
BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update
Reig, M., Forner, A., Rimola, J., Ferrer-Fàbrega, J., Burrel, M., Garcia-Criado, Á., Kelley, R. K., Galle, P. R., Mazzaferro, V., Salem, R., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.11.018 · Cited by 4,319
Rahbari, N. N., Garden, O. J., Padbury, R., Brooke-Smith, M., Crawford, M., Adam, R., Koch, M., Makuuchi, M., Dematteo, R. P., Christophi, C., et al. (2011) · Surgery · doi:10.1016/j.surg.2010.10.001 · Cited by 2,319
Global burden of liver disease: 2023 update
Devarbhavi, H., Asrani, S. K., Arab, J. P., Nartey, Y. A., Pose, E., & Kamath, P. S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.017 · Cited by 2,267
Self-citationLiver fibrosis – from bench to bedside
Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780
Zimmerman, J. E., Kramer, A. A., McNair, D. S., & Malila, F. M. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000215112.84523.f0 · Cited by 1,764
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
Sanyal, A. J., Van Natta, M. L., Clark, J., Neuschwander-Tetri, B. A., Diehl, A., Dasarathy, S., Loomba, R., Chalasani, N., Kowdley, K., Hameed, B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2029349 · Cited by 1,146
Martin, P., DiMartini, A., Feng, S., Brown, R., & Fallon, M. (2014) · Hepatology · doi:10.1002/hep.26972 · Cited by 1,045
Primary sclerosing cholangitis – a comprehensive review
Karlsen, T. H., Folseraas, T., Thorburn, D., & Vesterhus, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.022 · Cited by 868
EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.04.004 · Cited by 720
Guidelines on the management of ascites in cirrhosis
Aithal, G. P., Palaniyappan, N., China, L., Härmälä, S., Macken, L., Ryan, J. M., Wilkes, E. A., Moore, K., Leithead, J. A., Hayes, P. C., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321790 · Cited by 680
Darwish Murad, S., Kim, W. R., Harnois, D. M., Douglas, D. D., Burton, J., Kulik, L. M., Botha, J. F., Mezrich, J. D., Chapman, W. C., Schwartz, J. J., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.008 · Cited by 597
Development of a novel frailty index to predict mortality in patients with end‐stage liver disease
Lai, J. C., Covinsky, K. E., Dodge, J. L., Boscardin, W. J., Segev, D. L., Roberts, J. P., & Feng, S. (2017) · Hepatology · doi:10.1002/hep.29219 · Cited by 556
“The MELD score has proven, time and time again, to predict mortality in patients with cirrhosis.((1,15)) However, clinicians have long recognized that, at a given MELD score, the clinical manifestations of patients with ESLD are highly heterogeneous.”
BackgroundMethodInfluentialLammers, W. J., van Buuren, H. R., Hirschfield, G. M., Janssen, H. L. A., Invernizzi, P., Mason, A. L., Ponsioen, C. Y., Floreani, A., Corpechot, C., Mayo, M. J., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.029 · Cited by 498
Kharaziha, P., Hellström, P. M., Noorinayer, B., Farzaneh, F., Aghajani, K., Jafari, F., Telkabadi, M., Atashi, A., Honardoost, M., Zali, M. R., et al. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832a1f6c · Cited by 492
Rana, A., Hardy, M. A., Halazun, K. J., Woodland, D. C., Ratner, L. E., Samstein, B., Guarrera, J. V., Brown, R. S., & Emond, J. C. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02400.x · Cited by 459
Lammers, W. J., Hirschfield, G. M., Corpechot, C., Nevens, F., Lindor, K. D., Janssen, H. L. A., Floreani, A., Ponsioen, C. Y., Mayo, M. J., Invernizzi, P., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.061 · Cited by 441
Wijdicks, E. F. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600561 · Cited by 444
Tischendorf, J. J. W., Hecker, H., Krüger, M., Manns, M. P., & Meier, P. N. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00872.x · Cited by 413
Hirschfield, G. M., Dyson, J. K., Alexander, G. J. M., Chapman, M. H., Collier, J., Hübscher, S., Patanwala, I., Pereira, S. P., Thain, C., Thorburn, D., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315259 · Cited by 362
Sertraline as a first-line treatment for cholestatic pruritus
Mayo, M. J., Handem, I., Saldana, S., Jacobe, H., Getachew, Y., & Rush, J. A. (2007) · Hepatology · doi:10.1002/hep.21553 · Cited by 329
Blockchain and Artificial Intelligence Technology in E-Health
Tagde, P., Tagde, S., Bhattacharya, T., Tagde, P., Chopra, H., Akter, R., Kaushik, D., & Rahman, M. H. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16223-0 · Cited by 281
Evolving Frequency and Outcomes of Liver Transplantation Based on Etiology of Liver Disease
Singal, A. K., Guturu, P., Hmoud, B., Kuo, Y.-F., Salameh, H., & Wiesner, R. H. (2013) · Transplantation · doi:10.1097/tp.0b013e31827afb3a · Cited by 278
Self-citationCharatcharoenwitthaya, P., Pimentel, S., Talwalkar, J. A., Enders, F. T., Lindor, K. D., Krom, R. A. F., & Wiesner, R. H. (2007) · Liver Transplantation · doi:10.1002/lt.21124 · Cited by 179
Self-citationThe MELD score in patients awaiting liver transplant: Strengths and weaknesses
Bernardi, M., Gitto, S., & Biselli, M. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.008 · Cited by 174
Briceño, J., Cruz-Ramírez, M., Prieto, M., Navasa, M., Ortiz de Urbina, J., Orti, R., Gómez-Bravo, M.-Á., Otero, A., Varo, E., Tomé, S., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.039 · Cited by 152
Carbone, M., Bufton, S., Monaco, A., Griffiths, L., Jones, D. E., & Neuberger, J. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.017 · Cited by 115
Development and Validation of a Model Predicting Graft Survival after Liver Transplantation
Ioannou, G. N. (2006) · Liver Transplantation · doi:10.1002/lt.20764 · Cited by 115
When is liver biopsy needed in the diagnosis of primary biliary cirrhosis?
Zein, C. O., Angulo, P., & Lindor, K. D. (2003) · Clinical Gastroenterology and Hepatology · doi:10.1053/cgh.2003.50014 · Cited by 99
Amended fused TOPSIS-VIKOR for classification (ATOVIC) applied to some UCI data sets
Baccour, L. (2018) · Expert Systems with Applications · doi:10.1016/j.eswa.2018.01.025 · Cited by 98
Fosby, B., Melum, E., Bjøro, K., Bennet, W., Rasmussen, A., Andersen, I. M., Castedal, M., Olausson, M., Wibeck, C., Gotlieb, M., et al. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1036359 · Cited by 99
Ahluwalia, V., Wade, J. B., Heuman, D. M., Hammeke, T. A., Sanyal, A. J., Sterling, R. K., Stravitz, R. T., Luketic, V., Siddiqui, M. S., Puri, P., et al. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9507-6 · Cited by 92
Prolonged waiting times for liver transplantation in obese patients
Segev, D. L., Thompson, R. E., Locke, J. E., Simpkins, C. E., Thuluvath, P. J., Montgomery, R. A., & Maley, W. R. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31818a01ef · Cited by 91
Silveira, M. G., Brunt, E. M., Heathcote, J., Gores, G. J., Lindor, K. D., & Mayo, M. J. (2010) · Hepatology · doi:10.1002/hep.23637 · Cited by 87
Miroliaee, A., Nasiri-Toosi, M., Khalilzadeh, O., Esteghamati, A., Abdollahi, A., & Mazloumi, M. (2010) · Hepatology International · doi:10.1007/s12072-010-9194-2 · Cited by 82
Cruz-Ramírez, M., Hervás-Martínez, C., Fernández, J. C., Briceño, J., & de la Mata, M. (2013) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2013.02.004 · Cited by 79
Use of reclassification for assessment of improved prediction: an empirical evaluation
Tzoulaki, I., Liberopoulos, G., & Ioannidis, J. P. A. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr013 · Cited by 70
Brandsæter, B., Broomé, U., Isoniemi, H., Friman, S., Hansen, B., Schrumpf, E., Oksanen, A., Ericzon, B.-G., Höckerstedt, K., Mäkisalo, H., et al. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50169 · Cited by 71
Liver Fibrosis Leading to Cirrhosis: Basic Mechanisms and Clinical Perspectives
Somnay, K., Wadgaonkar, P., Sridhar, N., Roshni, P., Rao, N., & Wadgaonkar, R. (2024) · Biomedicines · doi:10.3390/biomedicines12102229 · Cited by 70
Systematic Review and Validation of Prognostic Models in Liver Transplantation
Jacob, M., Lewsey, J. D., Sharpin, C., Gimson, A., Rela, M., & van der Meulen, J. H. P. (2005) · Liver Transplantation · doi:10.1002/lt.20456 · Cited by 68
Rainer, F., Horvath, A., Sandahl, T. D., Leber, B., Schmerboeck, B., Blesl, A., Groselj‐Strele, A., Stauber, R. E., Fickert, P., Stiegler, P., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14474 · Cited by 65
Goldberg, D., French, B., Thomasson, A., Reddy, R. K., & Halpern, S. D. (2011) · Liver Transplantation · doi:10.1002/lt.22396 · Cited by 66
Karvellas, C. J., Garcia-Lopez, E., Fernandez, J., Saliba, F., Sy, E., Jalan, R., Pavesi, M., Gustot, T., Ronco, J. J., & Arroyo, V. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003369 · Cited by 62
Longo, C. R., Patel, V. I., Shrikhande, G. V., Scali, S. T., Csizmadia, E., Daniel, S., Sun, D. W., Grey, S. T., Arvelo, M. B., & Ferran, C. (2005) · Hepatology · doi:10.1002/hep.20741 · Cited by 60
Kim, D.-S., Yoon, Y.-I., Kim, B. K., Choudhury, A., Kulkarni, A., Park, J. Y., Kim, J., Sinn, D. H., Joo, D. J., Choi, Y., et al. (2024) · Hepatology International · doi:10.1007/s12072-023-10629-3 · Cited by 47
Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis
Buzzetti, E., Linden, A., Best, L. M., Madden, A. M., Roberts, D., Chase, T. J. G., Freeman, S. C., Cooper, N. J., Sutton, A. J., Fritche, D., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013156.pub2 · Cited by 46
Grigoriadis, A., Ringe, K. I., Andersson, M., Kartalis, N., & Bergquist, A. (2021) · European Journal of Radiology · doi:10.1016/j.ejrad.2021.109884 · Cited by 43
Garrido, M., Saccardo, D., De Rui, M., Vettore, E., Verardo, A., Carraro, P., Di Vitofrancesco, N., Mani, A. R., Angeli, P., Bolognesi, M., et al. (2017) · Liver International · doi:10.1111/liv.13525 · Cited by 38
Goldberg, D., Mantero, A., Newcomb, C., Delgado, C., Forde, K. A., Kaplan, D. E., John, B., Nuchovich, N., Dominguez, B., Emanuel, E., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.12.021 · Cited by 38
Nash, E. F., Volling, C., Gutierrez, C. A., Tullis, E., Coonar, A., McRae, K., Keshavjee, S., Singer, L. G., Durie, P. R., & Chaparro, C. (2012) · Clinical Transplantation · doi:10.1111/j.1399-0012.2010.01395.x · Cited by 37
Campbell, M. S., Lichtenstein, G. R., Rhim, A. D., Pazianas, M., & Faust, T. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01075.x · Cited by 34
Orandi, B. J., McLeod, M. C., MacLennan, P. A., Lee, W. M., Fontana, R. J., Karvellas, C. J., McGuire, B. M., Lewis, C. E., Terrault, N. M., Locke, J. E., et al. (2023) · JAMA · doi:10.1001/jama.2023.1080 · Cited by 30
Stine, J. G., Stukenborg, G. J., Wang, J., Adkins, A., Niccum, B., Zimmet, A., & Argo, C. K. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2019.06.018 · Cited by 27
Li, H.-Y., Li, B., Wei, Y.-G., Yan, L.-N., Wen, T.-F., Zhao, J.-C., Xu, M.-Q., Wang, W.-T., Ma, Y.-K., & Yang, J.-Y. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1817-5 · Cited by 25
Design of a multicenter randomized clinical trial for treatment of alcohol-associated hepatitis
Tu, W., Gawrieh, S., Dasarathy, S., Mitchell, M. C., Simonetto, D. A., Patidar, K. R., McClain, C. J., Bataller, R., Szabo, G., Tang, Q., et al. (2023) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2023.101074 · Cited by 21
Shamseddeen, H., Vilar-Gomez, E., Chalasani, N., Myers, R. P., Subramanian, G. M., Shlevin, H. H., Allgood, A. E., & Orman, E. S. (2020) · Drug Safety · doi:10.1007/s40264-019-00896-1 · Cited by 6
Metadata
- Authors
- Kamath, P. S., Wiesner, R. H., Malinchoc, M., Kremers, W., Therneau, T. M., Kosberg, C. L., D'Amico, G., Dickson, R. E., & Kim, R. W.
- Venue
- Hepatology
- Published
- 2001-02
- Volume
- 33
- Issue
- 2
- Pages
- 464-470
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2069243984
- Cited by
- 4,975
- References
- 5
- FWCI
- 63.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.